197 related articles for article (PubMed ID: 5081153)
1. [Effects of nicergoline on hemodynamics and metabolism of the brain in primary arterial hypertension and in arteriosclerosis].
Maiolo AT; Bianchi Porro G; Galli C; Sessa M
Clin Ter; 1972 Aug; 62(3):239-52. PubMed ID: 5081153
[No Abstract] [Full Text] [Related]
2. [Polygraphic evaluation of a new vasoactive drug (nicergoline)].
Baturic P; Cirignotta F
Minerva Cardioangiol; 1973 Oct; 21(10):664-7. PubMed ID: 4589189
[No Abstract] [Full Text] [Related]
3. [Clinical use of a new vasoactive drug : nicergoline].
Mellini M
Minerva Med; 1973 May; 64(34):1844-53. PubMed ID: 4719381
[No Abstract] [Full Text] [Related]
4. [Action of nicergoline on the cerebral circulatory insufficiency due to arteriosclerosis. Clinical and angioserographic evaluation].
Bernini FP; Muras I; Maglione F; Smaltino F
Farmaco Prat; 1977 Jan; 32(1):32-46. PubMed ID: 838039
[No Abstract] [Full Text] [Related]
5. [Serial angiographic evaluation of the effects of various vasoactive drugs on cerebral circulation in man].
Bernini FP; Smaltino F
Acta Neurol (Napoli); 1974 Mar; 29(2):170-84. PubMed ID: 4849693
[No Abstract] [Full Text] [Related]
6. [Current treatment of cerebrovascular disorder with vasoactive drugs].
Lebiediewa NW
Neurol Neurochir Pol; 1981; 15(4):417-21. PubMed ID: 6895779
[TBL] [Abstract][Full Text] [Related]
7. [The effect of sermion on the main hemodynamic indices in patients with the initial manifestations of cerebral atherosclerosis].
Tokar' AV; Akhaladze NG; Ena LM; Rudaia ES; Severova NL
Vrach Delo; 1990 Feb; (2):27-30. PubMed ID: 2339544
[TBL] [Abstract][Full Text] [Related]
8. [Hemodynamic and metabolic technic of study of a drug with cerebrovascular action].
Espagno J; Lazorthes Y; Arbus L
Therapeutique; 1969 Nov; 45(9):888-90. PubMed ID: 5365416
[No Abstract] [Full Text] [Related]
9. [Internal therapy of aging processes of the brain and its vessels].
Gottstein U
Wien Klin Wochenschr; 1969 Jun; 81(24):441-6. PubMed ID: 5351157
[No Abstract] [Full Text] [Related]
10. [Effectiveness of nicergoline in the treatment of chronic cerebrovascular insufficiency (author's transl)].
Kaemmerer E
Nervenarzt; 1980 Jun; 51(6):368-72. PubMed ID: 7453888
[No Abstract] [Full Text] [Related]
11. [Effect of sulfocamphocaine on the systemic and cerebral hemodynamics of patients with chronic cerebral circulatory failure].
Ishchenko MM; Shkrobot SI
Vrach Delo; 1984 Jul; (7):68-70. PubMed ID: 6475025
[No Abstract] [Full Text] [Related]
12. [Therapeutic action of nicergoline in the treatment of cerebrovascular and peripheral disorders].
Pasotti C; Liverta C; Cacciatori D; Pollini C
Farmaco Prat; 1974 Sep; 29(9):508-19. PubMed ID: 4608968
[No Abstract] [Full Text] [Related]
13. [Characteristics of the action of gemiton, adelfan and dopegit on cerebral circulation in arterial hypertension].
Eninia GI; Smeltere ES; Godlevska MA; Uzulinia IP
Klin Med (Mosk); 1984 Mar; 62(3):100-3. PubMed ID: 6716915
[No Abstract] [Full Text] [Related]
14. [Changes in hemodynamics of the brain in hypertension and cerebral arteriosclerosis and their reflection in the electrical activity of the brain during inhalation of pure oxygen (I) and during inhalation of a mixture of oxygen with carbon dioxide (II)].
Bajer A; Kameník A
Vnitr Lek; 1968 Sep; 14(9):833-40. PubMed ID: 5697936
[No Abstract] [Full Text] [Related]
15. [Hemodynamic principles of therapygin cerebrovascular diseases].
Klein K
Med Klin; 1973 May; 68(18):572-9. PubMed ID: 4576604
[No Abstract] [Full Text] [Related]
16. [Studies of the administration of ustimon and instenon in cerebrovascular diseases].
Pichler E; Strauss A
Wien Klin Wochenschr; 1968 Jan; 80(4):61-4 passim. PubMed ID: 5667714
[No Abstract] [Full Text] [Related]
17. [The effects of midazolam on the general circulation, cerebral blood-flow and cerebral oxygen consumption in man (author's transl)].
Larsen R; Hilfiker O; Radke J; Sonntag H
Anaesthesist; 1981 Jan; 30(1):18-21. PubMed ID: 7469000
[TBL] [Abstract][Full Text] [Related]
18. [The dynamics of the cerebral circulation and of brain functional activity in patients with initial atherosclerotic encephalopathy under the influence of a single intravenous administration of sermion].
Mints AIa; Karaban' IN; Litvinenko AA
Farmakol Toksikol; 1991; 54(4):59-62. PubMed ID: 1786832
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic activity of nicergoline in cerebrovascular syndromes].
Toni E
Minerva Med; 1973 Nov; 64(84):4466-73. PubMed ID: 4771472
[No Abstract] [Full Text] [Related]
20. [Use of sermion in cerebral atherosclerosis patients with a history of ischemic stroke].
Tsimenko OA; Sosnov IuD; Kharchenko AP; Gaĭduk IuS
Vrach Delo; 1988 Jul; (7):24-7. PubMed ID: 3188456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
